Penserra Capital Management LLC Red Hill Biopharma Ltd. Transaction History

Penserra Capital Management LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 15, 2022	SELL	$2.31 - $5.85 $2,460 - $6,230	-1,065 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$4.55 - $10.36 $22 - $51	5 Added 0.47%	1,065 $4,000
Q2 2021 Aug 12, 2021	BUY	$5.98 - $7.51 $1,046 - $1,314	175 Added 19.77%	1,060 $7,000
Q1 2021 May 13, 2021	BUY	$6.98 - $11.29 $174 - $282	25 Added 2.91%	885 $6,000
Q4 2020 Feb 12, 2021	BUY	$7.81 - $10.39 $6,716 - $8,935	860 New	860 $6,000

40.4K

Ticker RDHL
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 63,823,500
Market Cap $465M
Description
RedHill Biopharma Ltd., a specialty biopharmaceutical company, primarily focuses on gastrointestinal and infectious diseases. The company promotes gastrointestinal drugs, including Movantik for opioid-induced constipation in adults with chronic non-cancer pain; Talicia for the treatment of Helicobacter pylori infection in adults; and Aemcolo for...

Get notified when there are updates to the investment portfolio of Penserra Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Penserra Capital Management LLC with notifications on news.